Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Ventyx Biosciences Inc

VTYX
2,32
-0,07 (-2,93%)
29 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/6/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 8-K - Current report
05/6/202422:21EDGAR2Form 8-K - Current report
05/6/202422:01GLOBEVentyx Biosciences Announces Positive Preclinical Data for..
16/5/202422:05GLOBEVentyx Biosciences to Participate in Three Upcoming Investor..
16/5/202414:12EDGAR2Form 8-K - Current report
16/5/202414:00GLOBEVentyx Biosciences Announces Appointment of Matthew Moore as..
09/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:01GLOBEVentyx Biosciences Reports First Quarter 2024 Financial..
02/5/202422:05GLOBEVentyx Biosciences to Report First Quarter 2024 Financial..
26/4/202411:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
19/4/202412:00PRNUSVentyx Biosciences, Inc. Securities Fraud Class Action..
16/4/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/4/202411:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
09/4/202412:10PRNUSInvestors in Ventyx Biosciences, Inc. Should Contact The..
05/4/202411:45PRNUSInvestors who lost money on Ventyx Biosciences, Inc.(VTYX)..
29/3/202410:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
26/3/202410:45PRNUSVentyx Biosciences, Inc. Sued for Securities Law Violations..
11/3/202414:01EDGAR2Form 8-K - Current report
11/3/202412:00GLOBEVentyx Biosciences Reports Clinical Data for its NLRP3..
11/3/202410:45PRNUSThe Gross Law Firm Reminds Ventyx Biosciences, Inc...
08/3/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
07/3/202414:45EDGAR2Form 8-K - Current report
07/3/202414:00GLOBEVentyx Biosciences Announces $100 Million Private Placement..
07/3/202411:45PRNUSClass Action Filed Against Ventyx Biosciences, Inc. (VTYX)..
06/3/202414:00GLOBEVentyx Biosciences to Participate in Two Upcoming Investor..
04/3/202414:00GLOBEVentyx Biosciences to Host Virtual Investor Event on March..
27/2/202422:08EDGAR2Form 8-K - Current report
27/2/202422:01GLOBEVentyx Biosciences Reports Fourth Quarter and Full Year 2023..
22/2/202413:00GLOBEVentyx Biosciences to Present Results of the Phase 2 Trial..
13/2/202422:09EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
06/2/202422:05GLOBEVentyx Biosciences to Participate in the Oppenheimer 34th..
04/1/202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202301:22EDGAR2Form 144 - Report of proposed sale of securities
21/12/202301:10EDGAR2Form 144 - Report of proposed sale of securities
19/12/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:30EDGAR2Form 8-K - Current report
22/11/202322:57EDGAR2Form 8-K - Current report
21/11/202322:05GLOBEVentyx Biosciences to Participate in the 35th Annual Piper..
10/11/202314:00GLOBEVentyx Biosciences to Participate in the Jefferies London..
09/11/202322:05EDGAR2Form 8-K - Current report
09/11/202322:01GLOBEVentyx Biosciences Reports Third Quarter 2023 Financial..
Apertura: 2,42 Min: 2,255 Max: 2,42
Chiusura: 2,39

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network